There is a growing interest in new medical technologies have significant benefits for patients diagnosed with neurodegenerative diseases. Due to the lack of evidence-based data, these technologies have not been approved for clinical use.
PMT Data Science
Offers data services and IRB enrollment to physicians, researchers, and drug development companies currently using or interested in NAD+
PMT Diagnostics
Validating and commercializing cutting edge oculomotor signature diagnostic technology [Parkinson’s, CTE/TBI]
PMT Therapeutics
Developing cGMP pharmaceutical grade NAD+ API and associated agents in compliance with FDA regulations
About Us…
PMT is a clinical diagnostic, therapeutics, and data science company. PMT was founded in 2019 and is headquartered in Charlottesville, VA, USA. PMT is focused on developing and validating new technologies, clinical protocols, and treatment options for the diagnosis and treatment of neurodegenerative diseases. Our initial focus is on developing new options for the diagnosis and treatment of Parkinson’s Disease (PD).
Click to learn more about PMT.
Focus Areas
Data Science
AI driven bioinformatic analysis of patient outcomes using HIPAA compliant data system
Therapeutics
Proprietary development of NAD+ and intravenous (IV) administration protocols
Diagnostics
Non-invasive, rapid diagnostic test for neurodegenerative diseases
PMT Data System Allows physicians to administer IV NAD+ treatment in compliance with FDA-EMA and State Board of Pharmacy regulations.
PMT will co-own all de-identified patient outcomes data necessary to develop propriety IV NAD+ protocols and conduct clinical trials to validate treatment efficacy.
Phone
(234) 234-3467
Location
12345 Performance Med Tech St.
Richmond, VA 23173
support@performancemedtech.com